CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastomaMasahiro Nishikawa, Takeharu Kunieda, Akihiro Inoue et al.|Cancer Medicine|2021Cited by 26
Hypoxia-induced phenotypic transition from highly invasive to less invasive tumors in glioma stem-like cells: Significance of CD44 and osteopontin as therapeutic targets in glioblastomaMasahiro Nishikawa, Takeharu Kunieda, Seiji Shigekawa et al.|Translational Oncology|2021Cited by 26
Quantitative measurement of peritumoral concentrations of glutamate, N-acetyl aspartate, and lactate on magnetic resonance spectroscopy predicts glioblastoma-related refractory epilepsyYawara Nakamura, Takeharu Kunieda, Akihiro Inoue et al.|Acta Neurochirurgica|2022Cited by 17
Prediction of Glioma Stemlike Cell Infiltration in the Non–Contrast-Enhancing Area by Quantitative Measurement of Lactate on Magnetic Resonance Spectroscopy in GlioblastomaAkihiro Inoue, Takeharu Kunieda, Masahiro Nishikawa et al.|World Neurosurgery|2021Cited by 14
Identification of CD44 as a Reliable Biomarker for Glioblastoma Invasion: Based on Magnetic Resonance Imaging and Spectroscopic Analysis of 5-Aminolevulinic Acid FluorescenceAkihiro Inoue, Takeharu Kunieda, Takanori Ohnishi et al.|Biomedicines|2023Cited by 12